Genflow Biosciences plc (LON:GENF – Get Free Report)’s stock price rose 12.8% during trading on Tuesday . The stock traded as high as GBX 2.20 and last traded at GBX 2.20. Approximately 15,020,131 shares changed hands during trading, an increase of 455% from the average daily volume of 2,705,425 shares. The stock had previously closed at GBX 1.95.
Genflow Biosciences Stock Performance
The firm has a market capitalization of £11.78 million, a P/E ratio of -4.38 and a beta of 2.24. The stock’s 50 day simple moving average is GBX 1.92 and its 200 day simple moving average is GBX 1.87.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
